Cancer survivors with type 2 diabetes mellitus (T2DM) face unique challenges in managing their diabetes care due to the long-term effects of cancer treatment. This article presents a comparative analysis of type 2 diabetes management quality indicators in cancer survivors, aiming to assess the quality of diabetes care and identify areas for improvement in this specific patient population [1]. The study examines various quality indicators, including glycemic control, blood pressure management, lipid profile, preventive care, and adherence to diabetes medications and screenings. By analyzing these indicators, healthcare providers can enhance diabetes management strategies and improve long-term outcomes for cancer survivors with T2DM [2].
